Clinical Trial Update: Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating the effectiveness, safety, and tolerability of anti-HER2 therapies as targeted treatment for ERBB2-positive breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Deraya University | Conditions: Breast Neoplasms, Oncology | Status: COMPLETED